The information you provide to the chat will be recorded to improve your experience and to contact you. Please read our privacy notice to see how we are processing and protecting your data. Click to view our Cookie Notice.
We'd love your feedback—take a quick survey to help us improve.
How can we help you today?

Stop outsourcing, start partnering: Redefining value in global clinical trial execution

On-demand webinar

As biopharma pipelines expand and development timelines compress, traditional outsourcing models are falling short. While they may add capacity, they rarely deliver
the agility, integration, or foresight needed to manage today’s global trial complexity.

With CDMO and NewAmsterdam Pharma working as one team, they designed a strategy that enabled them to:

  • Align supply with actual patient enrollment using real-time forecasting and simulation tools
  • Avoid delays, reduce waste, and maintain 100% on-time delivery
  • Balance cost, risk, and quality—without compromising patient access